Elevated free interleukin-18 associated with severity and mortality in prospective cohort study of 206 hospitalised COVID-19 patients

Elevated free interleukin-18 associated with severity and mortality in prospective cohort study of 206 hospitalised COVID-19 patients

Abstract Background Divergence between deterioration to life-threatening COVID-19 or clinical improvement occurs for most within the first 14 days of symptoms. Life-threatening COVID-19 shares clinical similarities with Macrophage Activation Syndrome, which can be driven by elevated Free Interleukin...

Full description

Bibliographic Details
Main Authors: Syed M. T. Nasser, Anas A. Rana, Rainer Doffinger, Andreas Kafizas, Tauseef A. Khan, Shuaib Nasser
Format: Article
Language:English
Published: SpringerOpen 2023-02-01
Series:Intensive Care Medicine Experimental
Subjects:
Cytokines
Inflammasomes
Pneumonia
Viral
Autoimmunity
Coronavirus
Online Access:https://doi.org/10.1186/s40635-022-00488-x

Similar Items

Similar Items